Biotechnology
Swiss companies operating in the same biotechnology industry
The table below has Swiss companies that operate under the same industry, biotechnology. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like LONZA GROUP AG, or spot the most traded options, such as KUROS N. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 AMGAMGEN INC | 129.18 B CHF | 239.902 CHF | +2.00% | 2 | 0.47 | 24.74 | 9.70 CHF | +53.72% | 3.10% | Health technology | Buy |
 CSJCSL LTD | 62.84 B CHF | 130.487 CHF | +1.95% | 6 | 0.04 | 27.12 | 4.81 CHF | +6.92% | 1.71% | Health technology | Strong buy |
 LO3LONZA GROUP AG | 38.95 B CHF | 569.984 CHF | −0.15% | 267 | 3.11 | 63.89 | 8.92 CHF | +0.51% | 0.70% | Health technology | Strong buy |
| LONNLONZA N | 38.95 B CHF | 569.8 CHF | −0.04% | 116.02 K | 1.29 | 63.87 | 8.92 CHF | +0.51% | 0.70% | Health technology | Strong buy |
 22UABIONTECH SEDR | 21.5 B CHF | 88.718 CHF | −1.08% | 41 | 2.48 | — | −3.04 CHF | −804.25% | 0.00% | Health technology | Buy |
 0QFMODERNA INC | 10.03 B CHF | 25.936 CHF | +1.53% | 60 | 0.21 | — | −7.72 CHF | +45.40% | 0.00% | Health technology | Neutral |
 BM8BIOMARIN PHARMA | 9.02 B CHF | 46.569 CHF | +6.46% | 1 K | 5.19 | 19.52 | 2.39 CHF | +147.50% | 0.00% | Health technology | Buy |
 1CGCRISPR THERAPEUTIC | 3.83 B CHF | 45.248 CHF | −2.46% | 4 | 0.03 | — | −4.00 CHF | −62.81% | 0.00% | Health technology | Buy |
 KURNKUROS N | 1.06 B CHF | 28.58 CHF | −1.58% | 84.62 K | 0.26 | — | −0.12 CHF | +69.27% | 0.00% | Health technology | Strong buy |
 38IINTELLIA THERAPEUT | 987.02 M CHF | 9.658 CHF | +18.60% | 300 | 1.64 | — | −4.63 CHF | +4.39% | 0.00% | Health technology | Buy |
 5CVCUREVAC NV | 979.41 M CHF | 4.287 CHF | −0.95% | 102 | 0.44 | 5.37 | 0.80 CHF | — | 0.00% | Health technology | Neutral |
 PPGNPOLYPEPTIDE N | 705.22 M CHF | 22.05 CHF | +3.28% | 17.15 K | 1.10 | — | −0.57 CHF | +62.88% | 0.00% | Health technology | Neutral |
 VLAVALNEVA SE | 437.15 M CHF | 2.601 CHF | +1.09% | 281 | 0.19 | — | −0.50 CHF | −191.70% | 0.00% | Health technology | Strong buy |
 AXD2HERON THERAPEUTICS | 245.77 M CHF | 1.683 CHF | −3.22% | 2.74 K | — | — | −0.05 CHF | +91.24% | 0.00% | Health technology | Strong buy |
 MOLNMOLECULAR PARTNERS N | 120.72 M CHF | 2.990 CHF | 0.00% | 7.47 K | 0.56 | — | −1.71 CHF | +4.14% | 0.00% | Health technology | Strong buy |
 GBYSANGAMO THERAPEUTI | 95.45 M CHF | 0.435 CHF | −7.25% | 7 K | 1.00 | — | −0.34 CHF | +79.72% | 0.00% | Health technology | Buy |
 BIOVBIOVERSYS N | — | 34.5 CHF | +0.88% | 535 | 0.21 | — | — | — | — | Health technology | Strong buy |